Medical treatment of pancreatitis are all, except -a) Cholestyramineb) Aprotininc) Calciumd) Glucagon
## **Core Concept**
The medical treatment of pancreatitis involves various strategies aimed at managing symptoms, preventing complications, and supporting pancreatic function. These treatments can include medications to reduce pancreatic secretions, manage pain, and address potential complications such as hypercalcemia.
## **Why the Correct Answer is Right**
The correct answer, which is not a standard treatment for pancreatitis, needs to be identified based on the effectiveness and current medical practice for managing pancreatitis.
## **Why Each Wrong Option is Incorrect**
- **Option A: Cholestyramine** - This is actually used in the treatment of pancreatitis. Cholestyramine can help manage pruritus associated with biliary obstruction, which can be a complication of pancreatitis, and it can also bind to bile acids in the intestine, reducing their feedback inhibition on the liver and thereby potentially reducing pancreatic secretions indirectly.
- **Option B: Aprotin** (Aprotinin) - This was investigated for its potential to reduce pancreatic inflammation by inhibiting proteolytic enzymes. However, its use has been limited due to concerns about its efficacy and safety profile.
- **Option C: Calcium** - Calcium is used in the treatment of pancreatitis, especially if there is hypocalcemia. Hypocalcemia can occur due to the formation of calcium soaps in the abdominal cavity and the action of lipolytic enzymes.
- **Option D: Glucagon** - Glucagon has been studied for its potential benefits in treating acute pancreatitis. It can decrease pancreatic secretions and potentially reduce the metabolic demands on the pancreas.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while many treatments have been explored for pancreatitis, not all have proven beneficial. Specifically, the use of certain protease inhibitors like aprotinin has been scrutinized due to lack of clear benefit and potential risks.
## **Correct Answer: B. Aprotin**